Sonoma Pharmaceuticals, Inc. — Director's Dealing 2012

Oct 2, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Oculus Innovative Sciences, Inc. (OCLS)
CIK: 0001367083
Period of Report: 2012-10-01

Reporting Person: French Gregory M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-10-01	Stock Option (Right to Buy)	$0.90	A	15000	Acquired	2022-10-01	Common Stock (15000)	Direct

Footnotes

F1: The option will vest in equal monthly increments over a period of one year.

F2: The option was granted by the Issuer as compensation for serving on the Issuer's Board of Directors.